University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Click HERE for Coronavirus COVID-19 Links for the UCSF Cancer Community

Community Advisory Board: Champions for Health Equity

Community Advisory Board: Champions for Health Equity

January 14, 2021

Over the past 15 years, the cancer center’s Community Advisory Board (CAB) has become one of UCSF’s most instrumental community outreach groups for improving health equity. In a Q&A below, CAB Chair Arnold Perkins and Dr. Kim Rhoads discuss why CABs are critical to the ...
'Invisible' Stem Cells Evade Natural Killer Cells Using Immune 'Off-Switch'

'Invisible' Stem Cells Evade Natural Killer Cells Using Immune 'Off-Switch'

January 8, 2021

UC San Francisco scientists have discovered a new way to control the immune system’s “natural killer” (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The findings could also be used to enhance the ability of ...
Cancer Metastasis is Target of New Research Initiative

Cancer Metastasis is Target of New Research Initiative

January 6, 2021

Six UC San Francisco researchers have won an Endeavor Award to build a new research collaborative at the University focused on decoding the “rulebook” of metastatic cancer as a pathway to new treatments. The Mark Foundation for Cancer Research established the awards to support research challenges that are too ...
Year in Review: 2020

Year in Review: 2020

December 16, 2020

This year was difficult for all of us, personally and collectively. The COVID-19 pandemic transformed every aspect of our lives and called for us to adapt in unprecedented ways. It was gratifying – yet not surprising – to see how the UCSF community met the  ...
UCSF, UCLA Gain FDA Approval for Prostate Cancer Imaging Technique

UCSF, UCLA Gain FDA Approval for Prostate Cancer Imaging Technique

December 1, 2020

The University of California’s two nationally ranked medical centers, UC San Francisco and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other ...